These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization) |
(I.R.S. Employer
Identification No.) |
||||||||||
|
|
|||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
☒ | Accelerated filer | ☐ | |||||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
|||||||||||
| Emerging growth company |
|
|||||||||||||
| Class |
Shares Outstanding as of October 17, 2025
|
|||||||
| Common stock, $0.001 par value per share |
|
|||||||
| Page | ||||||||
|
Item 1.
|
||||||||
|
September 30,
2025 |
December 31,
2024 |
||||||||||
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Marketable securities |
|
|
|||||||||
| Other current assets |
|
|
|||||||||
| Total current assets |
|
|
|||||||||
| Property and equipment, net |
|
|
|||||||||
| Goodwill |
|
|
|||||||||
| Deferred tax assets |
|
|
|||||||||
| Deposits to acquire intangible assets |
|
|
|||||||||
| Other long-term assets |
|
|
|||||||||
| Total long-term assets |
|
|
|||||||||
| Total assets | $ |
|
$ |
|
|||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||
| Current liabilities: | |||||||||||
| Accounts payable and accrued liabilities | $ |
|
$ |
|
|||||||
| Deferred revenues |
|
|
|||||||||
| Current senior notes |
|
|
|||||||||
| Total current liabilities |
|
|
|||||||||
| Long-term deferred revenues |
|
|
|||||||||
| Long-term senior notes |
|
|
|||||||||
| Long-term tax and other liabilities |
|
|
|||||||||
| Total long-term liabilities |
|
|
|||||||||
| Total liabilities |
|
|
|||||||||
| Commitments and contingencies |
|
|
|||||||||
| Stockholders’ deficit: | |||||||||||
|
Preferred stock—par value $
|
|
|
|||||||||
|
Common stock and additional paid-in capital—par value $
|
|
|
|||||||||
| Accumulated deficit |
(
|
(
|
|||||||||
| Accumulated other comprehensive loss |
(
|
(
|
|||||||||
| Total stockholders’ deficit |
(
|
(
|
|||||||||
| Total liabilities and stockholders’ deficit | $ |
|
$ |
|
|||||||
|
|
Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Cost of revenues |
|
|
|
|
|||||||||||||||||||
| Research and development |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
| Total costs and expenses |
|
|
|
|
|||||||||||||||||||
| Operating income |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Non-operating income, net |
|
|
|
|
|||||||||||||||||||
| Income before income taxes |
|
|
|
|
|||||||||||||||||||
| Income tax expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||
| Other comprehensive income (loss) |
|
|
(
|
|
|||||||||||||||||||
| Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Earnings per share: | |||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Shares used to compute earnings per share | |||||||||||||||||||||||
| Basic |
|
|
|
|
|||||||||||||||||||
| Diluted |
|
|
|
|
|||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Total stockholders’ deficit, beginning of period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Common stock and additional paid-in capital | |||||||||||||||||||||||
| Beginning balance |
|
|
|
|
|||||||||||||||||||
| Repurchase of common stock |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Common stock cash dividends |
(
|
|
(
|
|
|||||||||||||||||||
| Stock-based compensation |
|
|
|
|
|||||||||||||||||||
| Issuance of common stock under stock plans |
|
|
|
|
|||||||||||||||||||
| Excise tax on repurchase of common stock |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Balance, end of period |
|
|
|
|
|||||||||||||||||||
| Accumulated deficit | |||||||||||||||||||||||
| Beginning balance |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income |
|
|
|
|
|||||||||||||||||||
| Balance, end of period |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||||||||||
| Beginning balance |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Other comprehensive income (loss) |
|
|
(
|
|
|||||||||||||||||||
| Balance, end of period |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Total stockholders’ deficit, end of period | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Cash dividends declared per common share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Nine Months Ended September 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| Cash flows from operating activities: | |||||||||||
| Net income | $ |
|
$ |
|
|||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||||||||
| Depreciation of property and equipment |
|
|
|||||||||
| Stock-based compensation expense |
|
|
|||||||||
| Amortization of discount on investments in debt securities |
(
|
(
|
|||||||||
| Other, net |
|
|
|||||||||
| Changes in operating assets and liabilities: | |||||||||||
| Other assets |
(
|
(
|
|||||||||
| Other liabilities |
|
(
|
|||||||||
| Deferred revenues |
|
|
|||||||||
| Net deferred income taxes |
|
|
|||||||||
| Net cash provided by operating activities |
|
|
|||||||||
| Cash flows from investing activities: | |||||||||||
| Proceeds from maturities and sales of marketable securities |
|
|
|||||||||
| Purchases of marketable securities |
(
|
(
|
|||||||||
| Purchases of property and equipment |
(
|
(
|
|||||||||
| Net cash provided by investing activities |
|
|
|||||||||
| Cash flows from financing activities: | |||||||||||
| Repurchases of common stock |
(
|
(
|
|||||||||
| Repayment of borrowings |
(
|
|
|||||||||
| Proceeds from senior note issuance, net of issuance costs |
|
|
|||||||||
| Payment of dividends |
(
|
|
|||||||||
| Proceeds from employee stock purchase plan |
|
|
|||||||||
| Payment of excise tax on repurchase of common stock |
(
|
|
|||||||||
| Net cash used in financing activities |
(
|
(
|
|||||||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash |
|
|
|||||||||
| Net increase in cash, cash equivalents, and restricted cash |
|
|
|||||||||
| Cash, cash equivalents, and restricted cash at beginning of period |
|
|
|||||||||
| Cash, cash equivalents, and restricted cash at end of period | $ |
|
$ |
|
|||||||
| Supplemental cash flow disclosures: | |||||||||||
| Cash paid for interest | $ |
|
$ |
|
|||||||
| Cash paid for income taxes, net of refunds received | $ |
|
$ |
|
|||||||
| September 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Cash | $ |
|
$ |
|
|||||||
| Time deposits |
|
|
|||||||||
| Money market funds (Level 1) |
|
|
|||||||||
| Debt securities issued by the U.S. Treasury (Level 1) |
|
|
|||||||||
| Total | $ |
|
$ |
|
|||||||
| Cash and cash equivalents | $ |
|
$ |
|
|||||||
| Restricted cash (included in Other long-term assets) |
|
|
|||||||||
| Total Cash, cash equivalents, and restricted cash |
|
|
|||||||||
| Marketable securities |
|
|
|||||||||
|
Total
|
$ |
|
$ |
|
|||||||
| September 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Prepaid expenses | $ |
|
$ |
|
|||||||
| Prepaid registry fees |
|
|
|||||||||
| Taxes receivable |
|
|
|||||||||
| Accounts receivable, net |
|
|
|||||||||
| Other |
|
|
|||||||||
| Total other current assets | $ |
|
$ |
|
|||||||
| September 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Operating lease right-of-use asset | $ |
|
$ |
|
|||||||
| Long-term prepaid registry fees |
|
|
|||||||||
| Long-term prepaid expenses |
|
|
|||||||||
| Restricted cash |
|
|
|||||||||
| Other |
|
|
|||||||||
| Total other long-term assets | $ |
|
$ |
|
|||||||
| September 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Accounts payable and accrued expenses | $ |
|
$ |
|
|||||||
| Customer deposits |
|
|
|||||||||
| Accrued employee compensation |
|
|
|||||||||
| Taxes payable |
|
|
|||||||||
| Interest payable |
|
|
|||||||||
| Accrued registry fees |
|
|
|||||||||
| Customer incentives payable |
|
|
|||||||||
| Current operating lease liabilities |
|
|
|||||||||
| Other accrued liabilities |
|
|
|||||||||
| Total accounts payable and accrued liabilities | $ |
|
$ |
|
|||||||
| Three Months Ended September 30, 2025 | Nine Months Ended September 30, 2025 | ||||||||||||||||||||||||||||||||||
| Shares | Total Costs | Average Price | Shares | Total Costs | Average Price | ||||||||||||||||||||||||||||||
| (In millions, except average price amounts) | |||||||||||||||||||||||||||||||||||
| Total repurchases under the repurchase plans |
|
$ |
|
$ |
|
|
$ |
|
$ |
|
|||||||||||||||||||||||||
| Total repurchases for tax withholdings |
|
|
$ |
|
|
|
$ |
|
|||||||||||||||||||||||||||
| Total repurchases |
|
$ |
|
$ |
|
|
$ |
|
$ |
|
|||||||||||||||||||||||||
|
Record Date
|
Payment Date
|
Dividend Per Share
|
Total
|
|||||||||||||||||
|
(In millions, except per share amounts)
|
||||||||||||||||||||
| April 23, 2025 | May 28, 2025 | $ |
|
$ |
|
|||||||||||||||
| July 22, 2025 | August 27, 2025 |
|
|
|||||||||||||||||
| $ |
|
$ |
|
|||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Weighted-average shares of common stock outstanding |
|
|
|
|
|||||||||||||||||||
| Weighted-average potential shares of common stock outstanding: | |||||||||||||||||||||||
| Unvested RSUs and ESPP |
|
|
|
|
|||||||||||||||||||
| Shares used to compute diluted earnings per share |
|
|
|
|
|||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Compensation and benefits expenses |
|
|
|
|
|||||||||||||||||||
| Stock-based compensation expenses |
|
|
|
|
|||||||||||||||||||
| Equipment and software expenses |
|
|
|
|
|||||||||||||||||||
| Registry fee expenses |
|
|
|
|
|||||||||||||||||||
| Depreciation expenses |
|
|
|
|
|||||||||||||||||||
| Other segment items |
|
|
|
|
|||||||||||||||||||
| Total costs and expenses |
|
|
|
|
|||||||||||||||||||
| Operating Income |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Non-operating income, net |
|
|
|
|
|||||||||||||||||||
| Income tax expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| U.S. | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| EMEA |
|
|
|
|
|||||||||||||||||||
|
APAC
|
|
|
|
|
|||||||||||||||||||
| Other |
|
|
|
|
|||||||||||||||||||
| Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| Cost of revenues | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Research and development |
|
|
|
|
|||||||||||||||||||
| Selling, general and administrative |
|
|
|
|
|||||||||||||||||||
| Stock-based compensation expense |
|
|
|
|
|||||||||||||||||||
| Capitalization (included in Property and equipment, net) |
|
|
|
|
|||||||||||||||||||
| Total stock-based compensation | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
| RSUs | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Performance-based RSUs |
|
|
|
|
|||||||||||||||||||
| ESPP |
|
|
|
|
|||||||||||||||||||
| Total stock-based compensation | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
|
Interest income
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
|
Other, net
|
(
|
|
(
|
|
|||||||||||||||||||
|
Total non-operating income, net
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||
| Income tax expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Effective tax rate |
|
% |
|
% |
|
% |
|
% | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| Revenues | 100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||||||||
| Costs and expenses: | |||||||||||||||||||||||
| Cost of revenues | 11.6 | 12.0 | 12.0 | 12.3 | |||||||||||||||||||
| Research and development | 6.1 | 5.9 | 6.3 | 6.2 | |||||||||||||||||||
| Selling, general and administrative | 14.5 | 13.2 | 13.8 | 13.1 | |||||||||||||||||||
| Total costs and expenses | 32.2 | 31.1 | 32.1 | 31.6 | |||||||||||||||||||
| Operating income | 67.8 | 68.9 | 67.9 | 68.4 | |||||||||||||||||||
| Interest expense | (4.5) | (4.8) | (4.7) | (4.9) | |||||||||||||||||||
| Non-operating income, net | 1.5 | 2.7 | 1.6 | 3.1 | |||||||||||||||||||
| Income before income taxes | 64.8 | 66.8 | 64.8 | 66.6 | |||||||||||||||||||
| Income tax expense | (14.0) | (15.3) | (14.5) | (15.5) | |||||||||||||||||||
| Net income | 50.8 | % | 51.5 | % | 50.3 | % | 51.1 | % | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | ||||||||||||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||||||||||||||
| Revenues | $ | 419.1 | 7% | $ | 390.6 | $ | 1,231.3 | 6% | $ | 1,162.0 | |||||||||||||||||||||||||
| September 30, 2025 | % Change | September 30, 2024 | |||||||||||||||
|
.com
and
.net
domain name registrations in the domain name base
|
171.9 million | 1% | 169.6 million | ||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | ||||||||||||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||||||||||||||
| U.S. | $ | 275.9 | 6% | $ | 260.2 | $ | 812.5 | 5% | $ | 773.2 | |||||||||||||||||||||||||
| EMEA | 71.2 | 13% | 62.8 | 207.0 | 12% | 184.7 | |||||||||||||||||||||||||||||
|
APAC
|
47.0 | 8% | 43.5 | 136.9 | 4% | 132.2 | |||||||||||||||||||||||||||||
| Other | 25.0 | 4% | 24.1 | 74.9 | 4% | 71.9 | |||||||||||||||||||||||||||||
| Total revenues | $ | 419.1 | $ | 390.6 | $ | 1,231.3 | $ | 1,162.0 | |||||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | ||||||||||||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||||||||||||||
| Cost of revenues | $ | 48.8 | 4% | $ | 46.8 | $ | 147.3 | 3% | $ | 143.0 | |||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | ||||||||||||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||||||||||||||
| Research and development | $ | 25.4 | 10% | $ | 23.2 | $ | 77.1 | 7% | $ | 71.8 | |||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||||||||||||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | ||||||||||||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||||||||||||||
| Selling, general and administrative | $ | 60.6 | 18% | $ | 51.3 | $ | 170.7 | 12% | $ | 152.8 | |||||||||||||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (In millions) | |||||||||||||||||||||||
|
Interest income
|
$ | 6.7 | $ | 8.7 | $ | 20.6 | $ | 30.4 | |||||||||||||||
|
Other, net
|
(0.4) | 1.8 | (1.3) | 5.5 | |||||||||||||||||||
|
Total non-operating income, net
|
$ | 6.3 | $ | 10.5 | $ | 19.3 | $ | 35.9 | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
| (Dollars in millions) | |||||||||||||||||||||||
| Income tax expense | $ | 58.9 | $ | 59.6 | $ | 177.9 | $ | 179.6 | |||||||||||||||
| Effective tax rate | 22 | % | 23 | % | 22 | % | 23 | % | |||||||||||||||
| September 30, | December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Cash and cash equivalents | $ | 235.4 | $ | 206.7 | |||||||
| Marketable securities | 382.3 | 393.2 | |||||||||
| Total | $ | 617.7 | $ | 599.9 | |||||||
| Nine Months Ended September 30, | |||||||||||
| 2025 | 2024 | ||||||||||
| (In millions) | |||||||||||
| Net cash provided by operating activities | $ | 801.5 | $ | 671.1 | |||||||
| Net cash provided by investing activities | 0.6 | 307.0 | |||||||||
| Net cash used in financing activities | (777.3) | (951.0) | |||||||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | 0.1 | 0.1 | |||||||||
| Net increase in cash, cash equivalents, and restricted cash | $ | 24.9 | $ | 27.2 | |||||||
|
Total Number
of Shares
Purchased
|
Average
Price Paid per Share |
Total Number
of Shares
Purchased as
Part of Publicly
Announced
Plans or
Programs (1)
|
Approximate
Dollar Value of
Shares That May
Yet Be Purchased
Under the Plans or
Programs (1) (2)
|
||||||||||||||||||||
| (Shares in thousands) | |||||||||||||||||||||||
|
July 1 - 31, 2025
|
169 | $ | 286.03 | 169 | $ | 1,494.9 | million | ||||||||||||||||
|
August 1 - 31, 2025
|
73 | $ | 272.75 | 73 | $ | 1,474.9 | million | ||||||||||||||||
|
September 1 - 30, 2025
|
521 | $ | 281.81 | 521 | $ | 1,328.2 | million | ||||||||||||||||
| 763 | 763 | ||||||||||||||||||||||
|
Exhibit
Number |
Exhibit Description | Incorporated by Reference | |||||||||||||||||||||||||||
| Form | Date | Number | Filed Herewith | ||||||||||||||||||||||||||
|
3.1
|
X
|
||||||||||||||||||||||||||||
| 31.01 | X | ||||||||||||||||||||||||||||
| 31.02 | X | ||||||||||||||||||||||||||||
| 32.01 | X | ||||||||||||||||||||||||||||
| 32.02 | X | ||||||||||||||||||||||||||||
| 101 | Interactive Data File. The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | X | |||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | X | |||||||||||||||||||||||||||
| * | As contemplated by SEC Release No. 33-8212, these exhibits are furnished with this Quarterly Report on Form 10-Q and are not deemed filed with the SEC and are not incorporated by reference in any filing of VeriSign, Inc. under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in such filings. | ||||
| VERISIGN, INC. | ||||||||
| Date: October 23, 2025 | By: |
/
S
/ D. J
AMES
B
IDZOS
|
||||||
| D. James Bidzos | ||||||||
| Chief Executive Officer | ||||||||
| Date: October 23, 2025 | By: |
/
S
/ JOHN D. CALYS
|
||||||
|
John D. Calys
|
||||||||
| Chief Financial Officer | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Anthem, Inc. | ANTM |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|